Skip to content

Cart

Your cart is empty

Independent clinical studies

Measured Performance

The finished ELIXIRA serum was evaluated in independent in vivo studies for hydration, skin comfort and pollution-particle adhesion.
+65.2%

Skin hydration after 1 hour

−25.1%

Pollution-particle adhesion vs untreated control

−37.2%

Residual particles after gentle cleansing

95%

Agreed skin felt more comfortable and nourished after 24 hours

−15.0%

Transepidermal water loss after 24 hours

Hydration & comfort study

Independent 24-hour in vivo clinical study conducted on the finished product with 30 volunteers.

Anti-pollution study

Independent randomized, assessor-blinded split-face clinical study conducted on the finished product; 32 enrolled and 31 completed.

Study details

How the results were measured

Both studies were carried out by an independent contract research organisation on the finished serum. Key protocol details and results are summarised below.

Hydration & skin barrier

Laboratory
Eurosafe CRO, France
Report reference
H24-AB-2025-09-001
Period
September 2025
Panel
30 healthy women, 25–55 years, dry to normal skin
Design
Single application (2 mg/cm²) on the forearm; untreated control area
Instruments
Corneometer® CM 825 (hydration), Tewameter® TM 300 (TEWL)
TimeSkin hydration (a.u.)Change vs baselineUntreated area
Baseline45.3—45.1
After 1 hour74.8+65.2%45.0
After 8 hours61.2+35.1%44.9
After 24 hours53.6+18.2%45.4

Differences versus the untreated area are statistically significant at every time point after application (p < 0.001).

Transepidermal water loss (TEWL) after 24 hours

10.6 → 8.9 g/m²/h (−15.0%, p < 0.01) · untreated area −1.0% (not significant)

Volunteer perception after 24 hours

  • 92% felt less tightness
  • 95% felt skin was more comfortable and nourished
  • 100% found the texture pleasant and fast-absorbing

Anti-pollution (split-face)

Laboratory
Eurosafe CRO, France
Report reference
ANT-PO-2026-03-11
Report date
March 2026
Panel
32 volunteers enrolled, 31 completed
Design
Single-centre, randomised, assessor-blinded split-face study; one half of the face treated, the other untreated
Method
2 mg/cm² applied, 15-minute film formation, exposure to standardised pollution-like particles, image analysis before and after gentle cleansing
MeasureUntreatedELIXIRAChange
Particle-covered area (%)18.714.0−25.1%
Residual particles after gentle cleansing (%)12.98.1−37.2%
Particle density index1.000.76−24.0%

All differences are statistically significant (p ≤ 0.002).

Tolerance

No serious adverse events. Mild, transient redness or stinging was reported by 5 of 32 volunteers.

Results relate to the conditions of each study and may vary between individuals. ELIXIRA helps reduce the adhesion of pollution particles; it does not claim complete protection. Documentation for distributors and professionals is available on request.

Tested under dermatological supervision.

Individual results may vary.